排序方式: 共有343条查询结果,搜索用时 15 毫秒
161.
Mercedes García-Bermúdez Raquel López-Mejías Carlos González-Juanatey Alfonso Corrales Gema Robledo Santos Casta?eda José A. Miranda-Filloy Ricardo Blanco Benjamín Fernández-Gutiérrez Alejandro Balsa Isidoro González-Alvaro Carmen Gómez-Vaquero Javier Llorca Javier Martín Miguel A. González-Gay 《PloS one》2012,7(10)
Objective
Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with increased cardiovascular (CV) morbidity and mortality. Since interferon-gamma (IFN-γ) has a direct effect on inflammation, in this study we assessed the potential association of the IFNG functional gene variant rs2430561 with CV disease in patients with RA.Methods
One thousand six hundred and thirty-five patients fulfilling the 1987 American College of Rheumatology classification criteria for RA were genotyped for the IFNG (rs2430561, +874T/A) gene polymorphism using TaqMan genotyping assay. Patients were stratified according to the presence of CV events or not. Logistic regression models to explain the presence of CV disease according to the IFNG rs2430561 allele distribution were performed. The potential influence of this variant in the development of subclinical atherosclerosis was also analyzed in a subgroup of patients with no history of CV events to determine carotid artery intima-media thickness (IMT) (n = 286) and presence of carotid plaques. Levels of the cytokine were determined in a subgroup of patients by ELISA.Results
Adjusted logistic regression model disclosed that presence of the minor allele A was not associated with increased risk of suffering CV events in RA patients. Besides, differences did not achieve statistical significance regarding carotid IMT and presence of carotid plaques in RA patients carrying IFNG rs2430561 variant allele. Levels of IFN-γ were higher in patients who had suffered CV events compared to patients who did not.Conclusion
Our results do not support a role of IFNG rs2430561 (+874T/A) functional gene variant in the development of CV disease in RA patients. 相似文献162.
Robledo G Dávila-Fajardo CL Márquez A Ortego-Centeno N Callejas Rubio JL de Ramón Garrido E Sánchez-Román J García-Hernández FJ Ríos-Fernández R González-Escribano MF Camps García MT Castillo Palma MJ Ayala Mdel M Martín J 《DNA and cell biology》2012,31(9):1486-1491
Rituximab has become a pivotal treatment for systemic autoimmune diseases. The aim of this study was to determine whether the genetic variant -174 IL-6 contributes to differences in the response to rituximab in patients with systemic autoimmune diseases, including systemic lupus erythematosus (SLE), inflammatory myopathies, anti-neutrophil cytoplasmic antibody-mediated vasculitis, systemic sclerosis, Sj?egren's syndrome, rheumatoid arthritis, and autoimmune hemolytic anemia. DNA samples from 144 Spanish patients with different systemic autoimmune diseases receiving rituximab were genotyped for -174 IL-6 (rs1800795) gene polymorphism using the TaqMan(?) allelic discrimination technology. Six months after the first infusion with rituximab, we evaluated the response to the drug: 60.4% of the patients showed a complete response, partial 27.8%, and 11.8% did not respond to the treatment. The CC genotype frequency was significantly increased in nonresponders with respect to responders (23.5% vs. 7.1%, respectively; p=0.049; odds ratio (OR)=4.03, 95% confidence intervals (CI) 0.78-16.97). According to the genotype distribution, rituximab was effective in 69.2% of the CC carriers, 91.9% of the CG carriers, and 88.4% of the GG carriers. A similar trend was observed when SLE patients were analyzed separately (27.3% carried CC homozygosis in nonresponders and 6.9% in responders; p=0.066; OR=5.10, 95% CI 0.65-31.73). Rituximab was effective in 62.5% of the CC carriers, 88.9% of the GC carriers, and 90% of the GG carriers. These results suggest that -174 IL-6 (rs1800795) gene polymorphism plays a role in the response to rituximab in systemic autoimmune diseases. Validation of these findings in independent cohorts is warranted. 相似文献
163.
164.
Adeva MM Souto G Donapetry C Portals M Rodriguez A Lamas D 《Neurochemistry international》2012,61(2):166-174
Cerebral edema is a potentially life-threatening complication shared by diseases of different etiology, such as diabetic ketoacidosis, acute liver failure, high altitude exposure, dialysis disequilibrium syndrome, and salicylate intoxication. Pulmonary edema is also habitually present in these disorders, indicating that the microcirculatory disturbance causing edema is not confined to the brain. Both cerebral and pulmonary subclinical edema may be detected before it becomes clinically evident. Available evidence suggests that tissue hypoxia or intracellular acidosis is a commonality occurring in all of these disorders. Tissue ischemia induces physiological compensatory mechanisms to ensure cell oxygenation and carbon dioxide removal from tissues, including hyperventilation, elevation of red blood cell 2,3-bisphosphoglycerate content, and capillary vasodilatation. Clinical, laboratory, and necropsy findings in these diseases confirm the occurrence of low plasma carbon dioxide partial pressure, increased erythrocyte 2,3-bisphosphoglycerate concentration, and capillary vasodilatation with increased vascular permeability in all of them. Baseline tissue hypoxia or intracellular acidosis induced by the disease may further deteriorate when tissue oxygen requirement is no longer matched to oxygen delivery resulting in massive capillary vasodilatation with increased vascular permeability and plasma fluid leakage into the interstitial compartment leading to edema affecting the brain, lung, and other organs. Causative factors involved in the progression from physiological adaptation to devastating clinical edema are not well known and may include uncontrolled disease, malfunctioning adaptive responses, or unknown factors. The role of carbon monoxide and local nitric oxide production influencing tissue oxygenation is unclear. 相似文献
165.
Diego A. Rodríguez Gema Alcarraz-Vizán Santiago Díaz-Moralli Michelle Reed Federico P. Gómez Francesco Falciani Ulrich Günther Josep Roca Marta Cascante 《Metabolomics : Official journal of the Metabolomic Society》2012,8(3):508-516
The study examines plasma metabolic profiles of patients with chronic obstructive pulmonary disease (COPD) to prove whether the disease influences metabolism at rest and after endurance training. This is based on the hypothesis that metabolome levels should reflect impaired skeletal muscle bioenergetics in COPD. The study aims to test this hypothesis by evaluating plasma metabolic profiles in COPD patients before and after 8?weeks of endurance exercise training. We studied blood samples from 18 COPD patients and 12 healthy subjects. Pre- and post-training blood plasma samples at rest and after constant-work rate exercise (CWRE) at 70% of pre-training Watts peak were analyzed by 1H-nuclear magnetic resonance spectroscopy to assess metabolite profiles. The two groups presented training-induced physiological changes in the VO2 peak and in blood lactate levels (P?<?0.01 each). Before training, the two groups also showed differences in metabolic profiles at rest (P?<?0.05). Levels of valine (r?=?0.51, P?<?0.01), alanine (r?=?0.45, P?<?0.05) and isoleucine (r?=?0.51, P?<?0.01) were positively associated with body composition (Fat Free Mass Index). While training showed a significant impact on the metabolic profile in healthy subjects (P?<?0.001), with changes in levels of amino acids, creatine, succinate, pyruvate, glucose and lactate (P?<?0.05 each), no equivalent training-induced effects were seen in COPD patients in whom only lactate decreased (P?<?0.05). This study shows that plasma metabolic profiling contributes to the phenotypic characterization of COPD patients. 相似文献
166.
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET 总被引:2,自引:0,他引:2
Peinado H Alecković M Lavotshkin S Matei I Costa-Silva B Moreno-Bueno G Hergueta-Redondo M Williams C García-Santos G Ghajar C Nitadori-Hoshino A Hoffman C Badal K Garcia BA Callahan MK Yuan J Martins VR Skog J Kaplan RN Brady MS Wolchok JD Chapman PB Kang Y Bromberg J Lyden D 《Nature medicine》2012,18(6):883-891
Tumor-derived exosomes are emerging mediators of tumorigenesis. We explored the function of melanoma-derived exosomes in the formation of primary tumors and metastases in mice and human subjects. Exosomes from highly metastatic melanomas increased the metastatic behavior of primary tumors by permanently 'educating' bone marrow progenitors through the receptor tyrosine kinase MET. Melanoma-derived exosomes also induced vascular leakiness at pre-metastatic sites and reprogrammed bone marrow progenitors toward a pro-vasculogenic phenotype that was positive for c-Kit, the receptor tyrosine kinase Tie2 and Met. Reducing Met expression in exosomes diminished the pro-metastatic behavior of bone marrow cells. Notably, MET expression was elevated in circulating CD45(-)C-KIT(low/+)TIE2(+) bone marrow progenitors from individuals with metastatic melanoma. RAB1A, RAB5B, RAB7 and RAB27A, regulators of membrane trafficking and exosome formation, were highly expressed in melanoma cells. Rab27A RNA interference decreased exosome production, preventing bone marrow education and reducing, tumor growth and metastasis. In addition, we identified an exosome-specific melanoma signature with prognostic and therapeutic potential comprised of TYRP2, VLA-4, HSP70, an HSP90 isoform and the MET oncoprotein. Our data show that exosome production, transfer and education of bone marrow cells supports tumor growth and metastasis, has prognostic value and offers promise for new therapeutic directions in the metastatic process. 相似文献
167.
168.
169.
170.
Gema Hernandez-Milian Sabine Goetz Catuxa Varela-Dopico José Rodriguez-Gutierrez Jorge Romón-Olea José R. Fuertes-Gamundi Edelmiro Ulloa-Alonso Nick J. C. Tregenza Andy Smerdon Monserrat G. Otero Vicente Tato Jianjun Wang M. Begoña Santos Alfredo López Rebeca Lago Julio M. Portela Graham J. Pierce 《Hydrobiologia》2008,612(1):251-268
In the Atlantic, economic losses have been reported from shark, swordfish and tuna longline fisheries due to depredation by
cetaceans. We examined interactions of odontocete cetaceans with commercial longliners operating in waters off Brazil and
the Azores archipelago during 2006–2007, analysing relationships between catches, depredation on hooked fish, cetacean sightings,
acoustic records of cetacean presence and environmental variables. Data were provided by skippers of six vessels and by on-board
observers for two vessels. The percentage of longline sets depredated by cetaceans was low (ranging from 1% to 9% of total
sets per ship) but the proportion of fish damaged was high (up to 100%) when depredation occurred. Catches were related to
the phase of the moon, cloud cover, sea surface temperature and water depth whereas cetacean sightings were primarily related
to catches. In particular there was a positive association between Delphinus delphis sightings and catches of swordfish, and between Stenella frontalis sightings and mako catches. Acoustic detection was low when depredation by false killer whales occurred although high rates
of clicks were detected when delphinids were sighted and false killer whales were by-caught. This may indicate that false
killer whales are not echolocating when feeding on fish hooked on a longline.
Guest editor: V. D. Valavanis
Essential Fish Habitat Mapping in the Mediterranean 相似文献